SCHEMBL7786898

SCHEMBL7786898

COc1ccc(-c2nc3cc(OCc4ccccc4)ccc3[nH]2)cc1C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 2/20 0.47
PDE4B Q07343 2/20 0.47
PDE4C Q08493 2/20 0.47
PDE4D Q08499 2/20 0.47
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
NR1I2 O75469 1/20 0.45
LMNA P02545 1/20 0.45
PGR P06401 1/20 0.45
RARA P10276 1/20 0.45
HSPD1 P10809 1/20 0.45
RARB P10826 1/20 0.45
RARG P13631 1/20 0.45
GOT1 P17174 1/20 0.45
GLRA1 P23415 1/20 0.45
BLM P54132 1/20 0.45
HSPE1 P61604 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
S1PR1 P21453 1/20 0.45
PRMT5 O14744 13/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7793501 0.94 PRMT5 (0.46) PDE4APDE4BPDE4CPDE4DPRMT5
SCHEMBL7786900 0.93 PDE4A (0.53) PDE4APDE4BPDE4CPDE4DMEN1
SCHEMBL7792893 0.93 PDE4A (0.47) PDE4APDE4BPDE4CPDE4DMEN1
SCHEMBL7786840 0.90 PDE4A (0.42) PDE4APDE4BPDE4CPDE4DMEN1
SCHEMBL7786839 0.88 PRMT5 (0.44) PDE4APDE4BPDE4CPDE4DPRMT5
SCHEMBL7786848 0.87 LMNA (0.50) PDE4APDE4BPDE4CPDE4DMEN1
SCHEMBL7793505 0.86 CHEK2 (0.49) PDE4APDE4BPDE4CPDE4DLMNA
SCHEMBL7792898 0.86 PDE4A (0.53) PDE4APDE4BPDE4CPDE4DMEN1
SCHEMBL9278077 0.84 PDE4A (0.47) PDE4APDE4BPDE4CPDE4DMEN1
SCHEMBL6571495 0.83 RARA (0.54) PDE4APDE4BPDE4CPDE4DMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0643701-B1 BENZIMIDAZOLE-DERIVED COMPOUNDS, METHOD FOR PREPARING SAME, AND THERAPEUTICAL AND COSMETIC USES THEREOF CT INTERNAT DE RECH S BR DERMA (FR) 2001-12-05 EP claimed
US-5446059-A Treating or preventing inflammatory or immunoallergic conditions CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) 1995-08-29 US claimed
EP-0643701-B1 BENZIMIDAZOLE-DERIVED COMPOUNDS, METHOD FOR PREPARING SAME, AND THERAPEUTICAL AND COSMETIC USES THEREOF CT INTERNAT DE RECH S BR DERMA (FR) 2001-12-05 EP disclosed
US-5446059-A Treating or preventing inflammatory or immunoallergic conditions CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) 1995-08-29 US disclosed
EP-0643701-A1 BENZIMIDAZOLE-DERIVED COMPOUNDS, METHOD FOR PREPARING SAME, AND THERAPEUTICAL AND COSMETIC USES THEREOF CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA, ( CIRD GALDERMA) (FR) 1995-03-22 EP disclosed
WO-1992021663-A1 BENZIMIDAZOLE-DERIVED COMPOUNDS, METHOD FOR PREPARING SAME, AND THERAPEUTICAL AND COSMETIC USES THEREOF CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) 1992-12-10 WO disclosed